Gallium
Name: Gallium
Indications and Usage for Gallium
Gallium Citrate Ga 67 Injection may be useful to demonstrate the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma. Positive Gallium Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Gallium Citrate Ga 67 Injection may be useful as an aid in detecting some acute inflammatory lesions.
Contraindications
None.
Warnings
None known.
Adverse Reactions
Rare occurrences of allergic reactions, skin rash and nausea have been reported in association with Gallium Citrate Ga 67 use.
Radiation dosimetry
The estimated absorbed radiation doses2 from an intravenous injection of 185 megabecquerels (5 millicuries) of Gallium Citrate Ga 67 are shown in Table 4.
| Tissue | mGy/ 185MBq | rads/ 5mCi |
| Whole Body | 13.0 | 1.30 |
| Skeleton | 22.0 | 2.20 |
| Liver | 23.0 | 2.30 |
| Bone Marrow | 29.0 | 2.90 |
| Spleen | 26.5 | 2.65 |
| Kidney | 20.5 | 2.05 |
| Ovaries | 14.0 | 1.40 |
| Testes | 12.0 | 1.20 |
| Gastrointestinal Tract | ||
| Stomach | 11.0 | 1.10 |
| Small Intestine | 18.0 | 1.80 |
| Upper Large Intestine | 28.0 | 2.80 |
| Lower Large Intestine | 45.0 | 4.50 |
Administrative Information
LactMed Record Number
665
Last Revision Date
20170411
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.